VC has been shown t o improve chemotaxis i n normal newborns. we evaluated i t s e f f e c t i n v i t r o on 1 1 s i c k term NBs, including 8 on a n t i b i o t i c s f o r undocumentel s e p s i s , on day 2-3 of l i f e . WBCs, separated from t h e blood, were divided i n t o 2 a l i q u o t s . One was incubated f o r 30 min with Hank's s o l u t i o n (HS) containi n g 20 pg/ml VC and t h e o t h e r with HS alone. I n a s e p a r a t e study 10 d i f f e r e n t term NBs with suspected sepsis were t r e a t e d with 4 doses of lOOmgs of VC q6h s t a r t i n g on day 2 of l i f e . Blood was drawn before and a f t e r VC treatment. Chemotaxis was determined by a modified Boyden's chamber technique. PMNs were deposited on a 3p m i l l i p o r e f i l t e r which divided t h e chamber i n t o an upper compartment f i l l e d with Hank's s o l u t i o n (HS), and lower f i l l e d with a mixture containing AB serum, endotoxin and HS. Following incubation and s t a i n i n g a r a t i o of miarated c e l l s t o t o t a l c e l l s was determined (CI). I n a p a r a l l e l run w i t h HS on e i t h e r s i d e t h e r a t i o was termed RM. VITAMIN T t h e r a~v of neonates has been associated with o l i g u r i a and . , r e n a l f a i l u r e which has not been s t u d i e d thoroughly. We have reported T dosing i n lambs t o r a p i d l y reach steady s t a t e (SS) plasma T concentrations. This study evaluated t h e e f f e c t s of T a t SS upon u r i n e output (UO) and t h e cardiovascular (CV) system i n c h r o n i c a l l y c a t h e t e r i z e d , r e s t i n g lambs. Similar 6-7 hour experiments were conducted on s e p a r a t e days i n the same lambs r e c e i v i n g e i t h e r c o n t r o l s a l i n e (C) (n=5) o r T (n=6) infusions. Experiments included study periods: l = c o n t r o l ; 2=reach T SS; 3,4,5=hourly s t u d i e s a t T SS; 6=T SS + double f l u i d i n t a k e .
Kiran Vohra, Abdul J. Khan, Warren Rosenfeld, Vrinda Telang, & Hugh E . Evans. Department of P e d i a t r i c s , I n t e r f a i t h Medical Center, SUNY/Downstate Medical Center, Brooklyn, New York.
VC has been shown t o improve chemotaxis i n normal newborns. we evaluated i t s e f f e c t i n v i t r o on 1 1 s i c k term NBs, including 8 on a n t i b i o t i c s f o r undocumentel s e p s i s , on day 2-3 of l i f e . WBCs, separated from t h e blood, were divided i n t o 2 a l i q u o t s . One was incubated f o r 30 min with Hank's s o l u t i o n (HS) containi n g 20 pg/ml VC and t h e o t h e r with HS alone. I n a s e p a r a t e study 10 d i f f e r e n t term NBs with suspected sepsis were t r e a t e d with 4 doses of lOOmgs of VC q6h s t a r t i n g on day 2 of l i f e . Blood was drawn before and a f t e r VC treatment. Chemotaxis was determined by a modified Boyden's chamber technique. PMNs were deposited on a 3p m i l l i p o r e f i l t e r which divided t h e chamber i n t o an upper compartment f i l l e d with Hank's s o l u t i o n (HS), and lower f i l l e d with a mixture containing AB serum, endotoxin and HS. Following incubation and s t a i n i n g a r a t i o of miarated c e l l s t o t o t a l c e l l s was determined (CI). I n a p a r a l l e l run w i t h HS on e i t h e r s i d e t h e r a t i o was termed RM. VITAMIN T t h e r a~v of neonates has been associated with o l i g u r i a and . , r e n a l f a i l u r e which has not been s t u d i e d thoroughly. We have reported T dosing i n lambs t o r a p i d l y reach steady s t a t e (SS) plasma T concentrations. This study evaluated t h e e f f e c t s of T a t SS upon u r i n e output (UO) and t h e cardiovascular (CV) system i n c h r o n i c a l l y c a t h e t e r i z e d , r e s t i n g lambs. Similar 6-7 hour experiments were conducted on s e p a r a t e days i n the same lambs r e c e i v i n g e i t h e r c o n t r o l s a l i n e (C) (n=5) o r T (n=6) infusions. Experiments included study periods: l = c o n t r o l ; 2=reach T SS; 3,4,5=hourly s t u d i e s a t T SS; 6=T SS + double f l u i d i n t a k e .
Fluid i n t a k e was constant a t 15.9f2.5ml/kg/hr during study periods 1-5 and not d i f f e r e n t between a l l C and T study periods. During C study periods 1-5, U O was constant a t 3.34t0.51 (mean ?SD) ml/kg/hr and increased t o 10.65i2.46ml/lsg/hr during period 6. CV parameters d i d n o t change during C, although volume expansion i n period 6 increased CI 30% (p=0.51). During T infus i o n , U O decreased from 3.0420.86 t o 0.6lml/kg/hr (p<.03) and returned t o 1.01t0.39ml/kg/hr by t h r e e hours. Volume expansion a t 33.9+5.9ml/kg/hr increased U O only t o 48% of c o n t r o l . When compared t o C, T produced t h e following C V changes: + h e a r t r a t e (p< .01); 4 c a r d i a c index (p<. 05); S a o r t i c pressure (p<.05) ; Ssystemic vascular r e s i s t a n c e (p<.02). These r e s u l t s i n d i c a t e T i n i t i a l l y i n h i b i t s i t s own elimination, possibly by d i l a t i n g p e r i p h e r a l v a s c u l a t u r e and d i v e r t i n g blood flow from t h e k i d n e y s Although volume expansion increased UO, i t d i d not r e t u r n t o t h e c o n t r o l r a t e s before beginning T infusion. A s p a r t o f a study of f a c t o r s a f f e c t i n g G'ph~rmacokinetios i n neonates, we recommended a modified dosing i n t e r v a l f o r preterm babies: q12O i f >38 wks g e s t a t i o n a l age (GA), q18' i f 30-37 wks GA, and q24O if-<30 wks GA.
After 3 doses, 3 G l e v e l s were drawn and pharmacokinetics analyzed. To evaluate t h e e f f e c t of t h e modified dosing schedule, we reviewed a 6 month period p r i o r t o the study (72 courses of therapy i n 67 p a t i e n t s (37 wks) and compared peak and trough l e v e l s with c a l c u l a t e d peak and trough l e v e l s from a 6 month period during t h e study (71 courses i n 65 p a t i e n t s (37 wks). Control (C) i n f a n t s had received G a t e0(2), 12O(56). 1e0(13) and 24'(1) i n t e r v a l s . Study (S) i n f a n t s received G a t ~' ( 2 ) . 12'(16), 18'(34) and 24'(19) i n t e r v a l s . The t a b l e shows values t h a t f e l l o u t s i d e t h e accepted t h e r a p e u t i c range.
G Rx Peak >10ug/ml Peak < 4~g / m l Trough >2pg/ml ,{28-32wk 27 0 2(7.4%) 13(48.1%) 33-37wk 45 2(4.4%) 4(9.3%) 31 (68.9%) ,{28-32wk 35 0 4(11.4%) 2 (5.6%)* 33-37wk 36 0 2(5.6%) 6(16.7%)* (*p<.001 f o r c o n t r o l vs. study) Of the 8 study i n f a n t s with troughs >2ug/ml, only 3 had a c t u a l l y been dosed a t t h e recommended i n t e r v a l . W e conclude t h a t t h i s simple modification of t h e G dosing i n t e r v a l i n t h e preterm neonate s i g n i f i c a n t l y decreases t h e number of elevated troughs without compromising t h e attainment of t h e r a p e u t i c peak l e v e l s .
INFLUENCE OF TOCOPHEROL VERSUS TOCOPHERYL ACETATE O N

LIPID EMULSION ENHANCED LIPID PEROXIDATION IN NEW-
BORN RABBITS. Jon R. Wisp$, Matthew E. Knight, and Robert J. Roberts. Depts. of P e d i a t r i c s & Pharmacol., College of Med., Univ. of Iowa Hospitals and C l i n i c s , Iowa City, IA 52242.
We have previously shown t h a t p a r e n t e r a l l i p i d emulsion i n c r e a s e s expired v o l a t i l e hydrocarbons, a s e n s i t i v e index of i n vivo l i p i d peroxidation. Newborn r a b b i t pups were randomly --given 100 mgjkg of tocopherol (T), tocopheryl a c e t a t e (TA) o r v e h i c l e placebo (P) IV. Expired hydrocarbons were q u a n t i t a t e d 18-24 h r s a f t e r i n i t i a t i o n of soy o i l emulsion i n f u s i o n (3-4 g of fat/kg/24 hrs). Tissues were then obtained f o r a n a l y s i s of t h i o b a r b i t u r i c acid (TBA) r e a c t a n t s , T and TA content and glutathione peroxidase a c t i v i t y (GP). Expired ethane values were 3, 36 and 99 pmo1/100 g body wt/min i n the T, TA and P groups, respectively. Expired pentane values were 10, 61 and 179 pmol/ 100 g body wt/min i n the T, TA and P groups. Ethane and pentane production was s i g n i f i c a n t l y d i f f e r e n t between groups (P<0.05). No d i f f e r e n c e s were found i n TBA r e a c t a n t s i n blood and lung o r lung GP a c t i v i t i e s . Liver TBA r e a c t a n t s were s i g n i f i c a n t l y d i ff e r e n t (P<0.05), 0.22, 0.35 and 0.70 nmol/mg t i s s u e i n t h e T, TA and P groups, respectively. Lung T l e v e l s were 79, 17 and 9 ~g / g of t i s s u e ; and l i v e r T l e v e l s were 393, 55 and 3 pg/g of t i s s u e i n t h e T, TA and P pups, respectively.
From these d a t a , we conclude t h a t t h e e x t e n t of i n vivo l i p i d peroxidation is proportional t o t h e T content i n t i s s u e . Admini s t r a t i o n of TA r e s u l t s i n s i g n i f i c a n t l y lower t i s s u e T content and, t h e r e f o r e , l e s s antioxidant a c t i v i t y a g a i n s t l i p i d emulsion enhanced l i p i d peroxidation. Previous study has shown t h a t F may prevent t h e r e n a l s i d e e ff e c t s of I i n i n f a n t s with PDA. We, t h e r e f o r e , undertook a study t o e v a l u a t e t h i s e f f e c t i n i n f a n t s with PDA and o l i g u r i a i n whom I therapy has been considered a s contraindicated. Six i n f a n t s (meanfS.D. E.W. 1.320.2 kg; G.A. 3222 wks, Postn. A. 9.6f2.8 days) who had s i g n . PDA shunt, congestive h e a r t f a i l u r e , and o l i g u r i a due t o pre-renal f a i l u r e were given I, 0.3 mgfkg, followed immed i a t e l y by F, 1 mglkg, i v . Pre-renal f a i l u r e was defined i f U/O was < l ml/kg/hr and i f FENa <2%. Cardiopulmonary s t a t u s and r e n a l f u n c t i o n s were evaluated before and a f t e r one dose of I and F. i n c r e a s e s i n U/O, FENa, FEcl, and GFR and s i g n . dec r e a s e s i n LA/AO, LVEDD were seen following I and F therapy. Four i n f a n t s responded w i t h ductus closure. Of t h e two whose duct u s remained open, t h e i r U/O, and FENa a l s o increased. This study i n d i c a t e s t h a t F can prevent f u r t h e r r e n a l dysfunctions expected from I therapy i n i n f a n t s who have PDA and a r e i n pre-renal f a i lure. A combination of I and F therapy can be s a f e l y used i n t h e s e i n f a n t s .
BUROSEMIDE (F) PREVENTS THE RENAL SIDE EFFECTS OF I N -
ENDOCRINOLOGY IS G H SECRETORY STATUS A DETERMINANT OF THE PITUITARY
426 TSH RESPONSE TO TRH. Val Abbassi,Georgetom Universit y Sch.of Med.,Dept. of P e d i a t r i c s , Washington,D.C. A suppressive G H e f f e c t on t h e p i t u i t a r y TSH responsiveness t o TRH and i n s t a n c e s of c l i n i c a l hypothyroidism developing i n children receiving G H therapy have been described. To f u r t h e r c i a r i T v ---t h e mechanism, 17 c h i l d r e n with G H d e f i c i e n c y were s t u d i e d . Eleven c h i l d r e n s u f f e r e d from i s o l a t e d G H deficiency (IGHD). S i x children, i n a d d i t i o n , had TSH deficiency a t t r i b u t a b l e t o TRH deficiency. Baseline thyroid s t u d i e s including Tq, RT3U, FT4 and TSH were determined i n a l l and a TRH t e s t (7 ug/kg IV) was performed p r i o r t o i n i t i a t i o n of G H therapy, 2 weeks post-therapy and subsequently a t 3 month i n t e r v a l s . I n c h i l d r e n with IGHD b a s e l i n e thyroid s t u d i e s were normal, and TSH response t o TRH was compara b l e t o c o n t r o l s . G H therapy up t o 12 months d i d not a l t e r thyr o i d function nor t h e TSH responsiveness t o TRH. (Table) TSH Children w i t h G H and TSH d e f i c i e n c i e s had v a r i a b l e b a s e l i n e thyr o i d l e v e l s and hyper-responsiveness t o TRH. The d a t a i n d i c a t e s t h a t i n IGHD p i t u i t a r y TRH responsiveness i s i n t a c t and t h a t G H therapy does n o t influence t h i s responsiveness. Routine T4 subs t i t u t i o n i n c h i l d r e n on G H therapy t h e r e f o r e , i s unwarranted.
